Related Experiment Video
Updated: Aug 12, 2026

Maintaining Aedes aegypti Mosquitoes Infected with Wolbachia
Published on: August 14, 2017
[Human onchocerciasis in Africa]
1ORSTOM, Paris, France.
Abstract:
Before the 1980s, the only available method for control of onchocerciasis was elimination of blackfly vector populations. This strategy was used with considerable success in the Onchocerciasis Control Programme in West Africa (OCP). The discovery of ivermectin, the first effective drug suitable for mass treatment of onchocerciasis, has revived international interest not only in fundamental research but also in development of new strategies to control onchocerciasis in the countries outside the OCP area. This report gives an overview of current parasitological, clinical, epidemiological and diagnostic data about onchocerciasis. Although little is known about the early development of Onchocerca volvulus in the human host, significant insight has been gained into the population dynamics of the parasite. The pathogenesis of cutaneous and ocular manifestations in onchocerciasis is now better understood. Epidemiological studies are under way to evaluate the extent of systemic manifestations. Recently developed diagnostic methods are more sensitive than conventional parasitological techniques. A new method for rapid assessment of endemic level has provided a detailed picture of the distribution of onchocerciasis. Species- and strain-specific DNA probes have been developed for identification of parasites in West Africa. New methods for quantifying disability allow evaluation of the socio-economic impact of the cutaneous and ocular complications of onchocerciasis.
Insights
Onchocerciasis control has evolved from vector elimination to mass drug administration with ivermectin. Current research focuses on understanding the parasite, disease, and developing advanced diagnostics for better control strategies.
Area of Science:
- Parasitology
- Clinical Medicine
- Epidemiology
- Diagnostic Development
Context:
- Historically, onchocerciasis control relied solely on blackfly vector elimination, notably in the Onchocerciasis Control Programme in West Africa (OCP).
- The advent of ivermectin revolutionized onchocerciasis treatment, enabling mass drug administration and renewed research interest globally.
- Focus has shifted to areas outside the OCP's former operational scope, necessitating updated control strategies.
Purpose:
- To provide a comprehensive overview of current knowledge on onchocerciasis.
- To highlight advancements in parasitological, clinical, epidemiological, and diagnostic aspects of the disease.
- To inform the development of new control strategies, particularly in regions previously unaddressed by large-scale programs.
Summary:
- Significant progress has been made in understanding Onchocerca volvulus population dynamics and the pathogenesis of cutaneous and ocular onchocerciasis.
- Epidemiological studies are expanding to assess systemic manifestations, while new diagnostic tools offer improved sensitivity over traditional methods.
- Novel diagnostic approaches, including DNA probes and rapid assessment methods, enhance parasite identification and mapping of endemic areas.
Impact:
- Improved diagnostic sensitivity aids in more accurate detection and monitoring of onchocerciasis.
- Enhanced understanding of disease pathogenesis informs clinical management and potentially preventative measures.
- New tools for quantifying disability allow for better assessment of the socio-economic burden of onchocerciasis complications.
Related Concept Videos
Symbiosis
Leishmaniasis
Malaria
Toxoplasmosis
American Trypanosomiasis
Amebiasis

